ORMP

#3133
Oramed Pharmaceuticals Inc.
3.42
0.00%
Sector:
Base:
Profit Currency:
Daily Range
3.42
3.42
Year Range
1.82
3.76
Daily Change
0.00%
Monthly Change
-1.16%
6 month change
+56.16%
Year Change
+61.32%
Previous Close
3.42
Open
3.42
Bid
Ask
Low
3.42
High
3.42
Volume
7
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 142.81 M
  • Employee 13
  • Founded 2006
  • CEO Nadav Kidron
  • Website www.oramed.com
  • Headquarter Delaware, United States
  • FIGI BBG000LRYR36
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.04
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Oramed Pharmaceuticals Inc

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

News